Journal: Cancer Medicine
Article Title: IGFL2‐AS1 ‐induced suppression of HIF ‐1α degradation promotes cell proliferation and invasion in colorectal cancer by upregulating CA9
doi: 10.1002/cam4.5562
Figure Lengend Snippet: CA9 is required for IGFL2‐AS1 to enhance CRC cell growth, migration, and invasion in vitro. (A) The effect of CA9 regulated by IGFL2‐AS1 on CRC cell viability was detected by CCK‐8 assay. (B, C) The quantitative results and images of the EdU assay showing that IGFL2‐AS1 regulates CRC cell proliferation through CA9. (D) The effect of CA9 overexpression and IGFL2‐AS1 knockdown co‐transfection on CRC cell proliferation was examined using a colony formation assay. (E, F) The effect of migration and invasion of IGFL2‐AS1 and CA9 co‐transfection in LoVo cells was determined by transwell assay. (magnification, 200× and 400×; scale bar, 25 μm; * p < 0.05, ** p < 0.01, *** p < 0.001)
Article Snippet: The slices were incubated with specific primary antibodies against CA9 (1:2000, ab243660, Abcam, Cambridge, UK), HIF‐1α (1:300, 66,730‐1‐Ig, Proteintech, Wuhan, China), and Ki67 (1:500, ab92742, Abcam, Cambridge, UK) overnight (14–16 h) at 4°C.
Techniques: Migration, In Vitro, CCK-8 Assay, EdU Assay, Over Expression, Cotransfection, Colony Assay, Transwell Assay